Global Femtech
Global Femtech

Femtech Comprehensive Study by Type (Devices, Software, Services), Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness, Others), End User (Direct-to-consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers) Players and Region - Global Market Outlook to 2025

Femtech Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Oct 2020 Edition 238 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Femtech Market Scope
Femtech is a service that focuses on the personal health and hygiene of women. It comprises period-tracking apps, fertility solutions, pregnancy & nursing care, reproductive system health, contraception as well as general healthcare and wellness. Growing demand for wearable devices to accurately monitor women's health conditions are key driving factors for the growth of femtech industry outlook worldwide. The market is expected to grow in the future due to the government as well as various public and private companies are rigorously investing in women health and hygiene sector.

The Femtech market study is segmented by Type (Devices, Software and Services), by Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Femtech market throughout the predicted period.

Sustain Natural (United States), Hera Med Ltd (Isreal), Totohealth (Kenya), Athena Feminine Technologies, Inc. (United States), iSono Health (United States), Sera Prognostics (United States), Elvie (United Kingdom), Univfy (United States) and Conceivable (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Femtech market by Type, Application and Region.

On the basis of geography, the market of Femtech has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • Introduction of innovative femtech solutions
  • Increasing market demand for embryo screening, egg freezing, fertility and other services

Market Drivers
  • Usage of digital technology to manage women health in developed countries
  • Improving access to women care in remote areas
  • Growing demand for wearable devices to accurately monitor women health conditions

Opportunities
  • Growing awareness regarding women health and wellness in developing countries
  • Increasing burden of chronic and infectious diseases among the female population

Restraints
  • Lack of high healthcare infrastructure in some region

Challenges
  • Lack of awareness about femtech products and applications


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations, End Use Industry and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Devices
  • Software
  • Services
By Application
  • Reproductive Health
  • Pregnancy & Nursing Care
  • Pelvic & Uterine Healthcare
  • General Healthcare & Wellness
  • Others
By End User
  • Direct-to-consumer
  • Hospitals
  • Fertility Clinics
  • Surgical Centers
  • Diagnostic Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Usage of digital technology to manage women health in developed countries
      • 3.2.2. Improving access to women care in remote areas
      • 3.2.3. Growing demand for wearable devices to accurately monitor women health conditions
    • 3.3. Market Challenges
      • 3.3.1. Lack of awareness about femtech products and applications
    • 3.4. Market Trends
      • 3.4.1. Introduction of innovative femtech solutions
      • 3.4.2. Increasing market demand for embryo screening, egg freezing, fertility and other services
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Femtech, by Type, Application, End User and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Femtech (Value)
      • 5.2.1. Global Femtech by: Type (Value)
        • 5.2.1.1. Devices
        • 5.2.1.2. Software
        • 5.2.1.3. Services
      • 5.2.2. Global Femtech by: Application (Value)
        • 5.2.2.1. Reproductive Health
        • 5.2.2.2. Pregnancy & Nursing Care
        • 5.2.2.3. Pelvic & Uterine Healthcare
        • 5.2.2.4. General Healthcare & Wellness
        • 5.2.2.5. Others
      • 5.2.3. Global Femtech by: End User (Value)
        • 5.2.3.1. Direct-to-consumer
        • 5.2.3.2. Hospitals
        • 5.2.3.3. Fertility Clinics
        • 5.2.3.4. Surgical Centers
        • 5.2.3.5. Diagnostic Centers
      • 5.2.4. Global Femtech Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Femtech: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sustain Natural (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hera Med Ltd (Isreal)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Totohealth (Kenya)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Athena Feminine Technologies, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ISono Health (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sera Prognostics (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Elvie (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Univfy (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Conceivable (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Femtech Sale, by Type, Application, End User and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Femtech (Value)
      • 7.2.1. Global Femtech by: Type (Value)
        • 7.2.1.1. Devices
        • 7.2.1.2. Software
        • 7.2.1.3. Services
      • 7.2.2. Global Femtech by: Application (Value)
        • 7.2.2.1. Reproductive Health
        • 7.2.2.2. Pregnancy & Nursing Care
        • 7.2.2.3. Pelvic & Uterine Healthcare
        • 7.2.2.4. General Healthcare & Wellness
        • 7.2.2.5. Others
      • 7.2.3. Global Femtech by: End User (Value)
        • 7.2.3.1. Direct-to-consumer
        • 7.2.3.2. Hospitals
        • 7.2.3.3. Fertility Clinics
        • 7.2.3.4. Surgical Centers
        • 7.2.3.5. Diagnostic Centers
      • 7.2.4. Global Femtech Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Femtech: by Type(USD Million)
  • Table 2. Femtech Devices , by Region USD Million (2014-2019)
  • Table 3. Femtech Software , by Region USD Million (2014-2019)
  • Table 4. Femtech Services , by Region USD Million (2014-2019)
  • Table 5. Femtech: by Application(USD Million)
  • Table 6. Femtech Reproductive Health , by Region USD Million (2014-2019)
  • Table 7. Femtech Pregnancy & Nursing Care , by Region USD Million (2014-2019)
  • Table 8. Femtech Pelvic & Uterine Healthcare , by Region USD Million (2014-2019)
  • Table 9. Femtech General Healthcare & Wellness , by Region USD Million (2014-2019)
  • Table 10. Femtech Others , by Region USD Million (2014-2019)
  • Table 11. Femtech: by End User(USD Million)
  • Table 12. Femtech Direct-to-consumer , by Region USD Million (2014-2019)
  • Table 13. Femtech Hospitals , by Region USD Million (2014-2019)
  • Table 14. Femtech Fertility Clinics , by Region USD Million (2014-2019)
  • Table 15. Femtech Surgical Centers , by Region USD Million (2014-2019)
  • Table 16. Femtech Diagnostic Centers , by Region USD Million (2014-2019)
  • Table 17. South America Femtech, by Country USD Million (2014-2019)
  • Table 18. South America Femtech, by Type USD Million (2014-2019)
  • Table 19. South America Femtech, by Application USD Million (2014-2019)
  • Table 20. South America Femtech, by End User USD Million (2014-2019)
  • Table 21. Brazil Femtech, by Type USD Million (2014-2019)
  • Table 22. Brazil Femtech, by Application USD Million (2014-2019)
  • Table 23. Brazil Femtech, by End User USD Million (2014-2019)
  • Table 24. Argentina Femtech, by Type USD Million (2014-2019)
  • Table 25. Argentina Femtech, by Application USD Million (2014-2019)
  • Table 26. Argentina Femtech, by End User USD Million (2014-2019)
  • Table 27. Rest of South America Femtech, by Type USD Million (2014-2019)
  • Table 28. Rest of South America Femtech, by Application USD Million (2014-2019)
  • Table 29. Rest of South America Femtech, by End User USD Million (2014-2019)
  • Table 30. Asia Pacific Femtech, by Country USD Million (2014-2019)
  • Table 31. Asia Pacific Femtech, by Type USD Million (2014-2019)
  • Table 32. Asia Pacific Femtech, by Application USD Million (2014-2019)
  • Table 33. Asia Pacific Femtech, by End User USD Million (2014-2019)
  • Table 34. China Femtech, by Type USD Million (2014-2019)
  • Table 35. China Femtech, by Application USD Million (2014-2019)
  • Table 36. China Femtech, by End User USD Million (2014-2019)
  • Table 37. Japan Femtech, by Type USD Million (2014-2019)
  • Table 38. Japan Femtech, by Application USD Million (2014-2019)
  • Table 39. Japan Femtech, by End User USD Million (2014-2019)
  • Table 40. India Femtech, by Type USD Million (2014-2019)
  • Table 41. India Femtech, by Application USD Million (2014-2019)
  • Table 42. India Femtech, by End User USD Million (2014-2019)
  • Table 43. South Korea Femtech, by Type USD Million (2014-2019)
  • Table 44. South Korea Femtech, by Application USD Million (2014-2019)
  • Table 45. South Korea Femtech, by End User USD Million (2014-2019)
  • Table 46. Taiwan Femtech, by Type USD Million (2014-2019)
  • Table 47. Taiwan Femtech, by Application USD Million (2014-2019)
  • Table 48. Taiwan Femtech, by End User USD Million (2014-2019)
  • Table 49. Australia Femtech, by Type USD Million (2014-2019)
  • Table 50. Australia Femtech, by Application USD Million (2014-2019)
  • Table 51. Australia Femtech, by End User USD Million (2014-2019)
  • Table 52. Rest of Asia-Pacific Femtech, by Type USD Million (2014-2019)
  • Table 53. Rest of Asia-Pacific Femtech, by Application USD Million (2014-2019)
  • Table 54. Rest of Asia-Pacific Femtech, by End User USD Million (2014-2019)
  • Table 55. Europe Femtech, by Country USD Million (2014-2019)
  • Table 56. Europe Femtech, by Type USD Million (2014-2019)
  • Table 57. Europe Femtech, by Application USD Million (2014-2019)
  • Table 58. Europe Femtech, by End User USD Million (2014-2019)
  • Table 59. Germany Femtech, by Type USD Million (2014-2019)
  • Table 60. Germany Femtech, by Application USD Million (2014-2019)
  • Table 61. Germany Femtech, by End User USD Million (2014-2019)
  • Table 62. France Femtech, by Type USD Million (2014-2019)
  • Table 63. France Femtech, by Application USD Million (2014-2019)
  • Table 64. France Femtech, by End User USD Million (2014-2019)
  • Table 65. Italy Femtech, by Type USD Million (2014-2019)
  • Table 66. Italy Femtech, by Application USD Million (2014-2019)
  • Table 67. Italy Femtech, by End User USD Million (2014-2019)
  • Table 68. United Kingdom Femtech, by Type USD Million (2014-2019)
  • Table 69. United Kingdom Femtech, by Application USD Million (2014-2019)
  • Table 70. United Kingdom Femtech, by End User USD Million (2014-2019)
  • Table 71. Netherlands Femtech, by Type USD Million (2014-2019)
  • Table 72. Netherlands Femtech, by Application USD Million (2014-2019)
  • Table 73. Netherlands Femtech, by End User USD Million (2014-2019)
  • Table 74. Rest of Europe Femtech, by Type USD Million (2014-2019)
  • Table 75. Rest of Europe Femtech, by Application USD Million (2014-2019)
  • Table 76. Rest of Europe Femtech, by End User USD Million (2014-2019)
  • Table 77. MEA Femtech, by Country USD Million (2014-2019)
  • Table 78. MEA Femtech, by Type USD Million (2014-2019)
  • Table 79. MEA Femtech, by Application USD Million (2014-2019)
  • Table 80. MEA Femtech, by End User USD Million (2014-2019)
  • Table 81. Middle East Femtech, by Type USD Million (2014-2019)
  • Table 82. Middle East Femtech, by Application USD Million (2014-2019)
  • Table 83. Middle East Femtech, by End User USD Million (2014-2019)
  • Table 84. Africa Femtech, by Type USD Million (2014-2019)
  • Table 85. Africa Femtech, by Application USD Million (2014-2019)
  • Table 86. Africa Femtech, by End User USD Million (2014-2019)
  • Table 87. North America Femtech, by Country USD Million (2014-2019)
  • Table 88. North America Femtech, by Type USD Million (2014-2019)
  • Table 89. North America Femtech, by Application USD Million (2014-2019)
  • Table 90. North America Femtech, by End User USD Million (2014-2019)
  • Table 91. United States Femtech, by Type USD Million (2014-2019)
  • Table 92. United States Femtech, by Application USD Million (2014-2019)
  • Table 93. United States Femtech, by End User USD Million (2014-2019)
  • Table 94. Canada Femtech, by Type USD Million (2014-2019)
  • Table 95. Canada Femtech, by Application USD Million (2014-2019)
  • Table 96. Canada Femtech, by End User USD Million (2014-2019)
  • Table 97. Mexico Femtech, by Type USD Million (2014-2019)
  • Table 98. Mexico Femtech, by Application USD Million (2014-2019)
  • Table 99. Mexico Femtech, by End User USD Million (2014-2019)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Femtech: by Type(USD Million)
  • Table 110. Femtech Devices , by Region USD Million (2020-2025)
  • Table 111. Femtech Software , by Region USD Million (2020-2025)
  • Table 112. Femtech Services , by Region USD Million (2020-2025)
  • Table 113. Femtech: by Application(USD Million)
  • Table 114. Femtech Reproductive Health , by Region USD Million (2020-2025)
  • Table 115. Femtech Pregnancy & Nursing Care , by Region USD Million (2020-2025)
  • Table 116. Femtech Pelvic & Uterine Healthcare , by Region USD Million (2020-2025)
  • Table 117. Femtech General Healthcare & Wellness , by Region USD Million (2020-2025)
  • Table 118. Femtech Others , by Region USD Million (2020-2025)
  • Table 119. Femtech: by End User(USD Million)
  • Table 120. Femtech Direct-to-consumer , by Region USD Million (2020-2025)
  • Table 121. Femtech Hospitals , by Region USD Million (2020-2025)
  • Table 122. Femtech Fertility Clinics , by Region USD Million (2020-2025)
  • Table 123. Femtech Surgical Centers , by Region USD Million (2020-2025)
  • Table 124. Femtech Diagnostic Centers , by Region USD Million (2020-2025)
  • Table 125. South America Femtech, by Country USD Million (2020-2025)
  • Table 126. South America Femtech, by Type USD Million (2020-2025)
  • Table 127. South America Femtech, by Application USD Million (2020-2025)
  • Table 128. South America Femtech, by End User USD Million (2020-2025)
  • Table 129. Brazil Femtech, by Type USD Million (2020-2025)
  • Table 130. Brazil Femtech, by Application USD Million (2020-2025)
  • Table 131. Brazil Femtech, by End User USD Million (2020-2025)
  • Table 132. Argentina Femtech, by Type USD Million (2020-2025)
  • Table 133. Argentina Femtech, by Application USD Million (2020-2025)
  • Table 134. Argentina Femtech, by End User USD Million (2020-2025)
  • Table 135. Rest of South America Femtech, by Type USD Million (2020-2025)
  • Table 136. Rest of South America Femtech, by Application USD Million (2020-2025)
  • Table 137. Rest of South America Femtech, by End User USD Million (2020-2025)
  • Table 138. Asia Pacific Femtech, by Country USD Million (2020-2025)
  • Table 139. Asia Pacific Femtech, by Type USD Million (2020-2025)
  • Table 140. Asia Pacific Femtech, by Application USD Million (2020-2025)
  • Table 141. Asia Pacific Femtech, by End User USD Million (2020-2025)
  • Table 142. China Femtech, by Type USD Million (2020-2025)
  • Table 143. China Femtech, by Application USD Million (2020-2025)
  • Table 144. China Femtech, by End User USD Million (2020-2025)
  • Table 145. Japan Femtech, by Type USD Million (2020-2025)
  • Table 146. Japan Femtech, by Application USD Million (2020-2025)
  • Table 147. Japan Femtech, by End User USD Million (2020-2025)
  • Table 148. India Femtech, by Type USD Million (2020-2025)
  • Table 149. India Femtech, by Application USD Million (2020-2025)
  • Table 150. India Femtech, by End User USD Million (2020-2025)
  • Table 151. South Korea Femtech, by Type USD Million (2020-2025)
  • Table 152. South Korea Femtech, by Application USD Million (2020-2025)
  • Table 153. South Korea Femtech, by End User USD Million (2020-2025)
  • Table 154. Taiwan Femtech, by Type USD Million (2020-2025)
  • Table 155. Taiwan Femtech, by Application USD Million (2020-2025)
  • Table 156. Taiwan Femtech, by End User USD Million (2020-2025)
  • Table 157. Australia Femtech, by Type USD Million (2020-2025)
  • Table 158. Australia Femtech, by Application USD Million (2020-2025)
  • Table 159. Australia Femtech, by End User USD Million (2020-2025)
  • Table 160. Rest of Asia-Pacific Femtech, by Type USD Million (2020-2025)
  • Table 161. Rest of Asia-Pacific Femtech, by Application USD Million (2020-2025)
  • Table 162. Rest of Asia-Pacific Femtech, by End User USD Million (2020-2025)
  • Table 163. Europe Femtech, by Country USD Million (2020-2025)
  • Table 164. Europe Femtech, by Type USD Million (2020-2025)
  • Table 165. Europe Femtech, by Application USD Million (2020-2025)
  • Table 166. Europe Femtech, by End User USD Million (2020-2025)
  • Table 167. Germany Femtech, by Type USD Million (2020-2025)
  • Table 168. Germany Femtech, by Application USD Million (2020-2025)
  • Table 169. Germany Femtech, by End User USD Million (2020-2025)
  • Table 170. France Femtech, by Type USD Million (2020-2025)
  • Table 171. France Femtech, by Application USD Million (2020-2025)
  • Table 172. France Femtech, by End User USD Million (2020-2025)
  • Table 173. Italy Femtech, by Type USD Million (2020-2025)
  • Table 174. Italy Femtech, by Application USD Million (2020-2025)
  • Table 175. Italy Femtech, by End User USD Million (2020-2025)
  • Table 176. United Kingdom Femtech, by Type USD Million (2020-2025)
  • Table 177. United Kingdom Femtech, by Application USD Million (2020-2025)
  • Table 178. United Kingdom Femtech, by End User USD Million (2020-2025)
  • Table 179. Netherlands Femtech, by Type USD Million (2020-2025)
  • Table 180. Netherlands Femtech, by Application USD Million (2020-2025)
  • Table 181. Netherlands Femtech, by End User USD Million (2020-2025)
  • Table 182. Rest of Europe Femtech, by Type USD Million (2020-2025)
  • Table 183. Rest of Europe Femtech, by Application USD Million (2020-2025)
  • Table 184. Rest of Europe Femtech, by End User USD Million (2020-2025)
  • Table 185. MEA Femtech, by Country USD Million (2020-2025)
  • Table 186. MEA Femtech, by Type USD Million (2020-2025)
  • Table 187. MEA Femtech, by Application USD Million (2020-2025)
  • Table 188. MEA Femtech, by End User USD Million (2020-2025)
  • Table 189. Middle East Femtech, by Type USD Million (2020-2025)
  • Table 190. Middle East Femtech, by Application USD Million (2020-2025)
  • Table 191. Middle East Femtech, by End User USD Million (2020-2025)
  • Table 192. Africa Femtech, by Type USD Million (2020-2025)
  • Table 193. Africa Femtech, by Application USD Million (2020-2025)
  • Table 194. Africa Femtech, by End User USD Million (2020-2025)
  • Table 195. North America Femtech, by Country USD Million (2020-2025)
  • Table 196. North America Femtech, by Type USD Million (2020-2025)
  • Table 197. North America Femtech, by Application USD Million (2020-2025)
  • Table 198. North America Femtech, by End User USD Million (2020-2025)
  • Table 199. United States Femtech, by Type USD Million (2020-2025)
  • Table 200. United States Femtech, by Application USD Million (2020-2025)
  • Table 201. United States Femtech, by End User USD Million (2020-2025)
  • Table 202. Canada Femtech, by Type USD Million (2020-2025)
  • Table 203. Canada Femtech, by Application USD Million (2020-2025)
  • Table 204. Canada Femtech, by End User USD Million (2020-2025)
  • Table 205. Mexico Femtech, by Type USD Million (2020-2025)
  • Table 206. Mexico Femtech, by Application USD Million (2020-2025)
  • Table 207. Mexico Femtech, by End User USD Million (2020-2025)
  • Table 208. Research Programs/Design for This Report
  • Table 209. Key Data Information from Secondary Sources
  • Table 210. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Femtech: by Type USD Million (2014-2019)
  • Figure 5. Global Femtech: by Application USD Million (2014-2019)
  • Figure 6. Global Femtech: by End User USD Million (2014-2019)
  • Figure 7. South America Femtech Share (%), by Country
  • Figure 8. Asia Pacific Femtech Share (%), by Country
  • Figure 9. Europe Femtech Share (%), by Country
  • Figure 10. MEA Femtech Share (%), by Country
  • Figure 11. North America Femtech Share (%), by Country
  • Figure 12. Global Femtech share by Players 2019 (%)
  • Figure 13. Global Femtech share by Players (Top 3) 2019(%)
  • Figure 14. Global Femtech share by Players (Top 5) 2019(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Sustain Natural (United States) Revenue, Net Income and Gross profit
  • Figure 17. Sustain Natural (United States) Revenue: by Geography 2019
  • Figure 18. Hera Med Ltd (Isreal) Revenue, Net Income and Gross profit
  • Figure 19. Hera Med Ltd (Isreal) Revenue: by Geography 2019
  • Figure 20. Totohealth (Kenya) Revenue, Net Income and Gross profit
  • Figure 21. Totohealth (Kenya) Revenue: by Geography 2019
  • Figure 22. Athena Feminine Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Athena Feminine Technologies, Inc. (United States) Revenue: by Geography 2019
  • Figure 24. ISono Health (United States) Revenue, Net Income and Gross profit
  • Figure 25. ISono Health (United States) Revenue: by Geography 2019
  • Figure 26. Sera Prognostics (United States) Revenue, Net Income and Gross profit
  • Figure 27. Sera Prognostics (United States) Revenue: by Geography 2019
  • Figure 28. Elvie (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Elvie (United Kingdom) Revenue: by Geography 2019
  • Figure 30. Univfy (United States) Revenue, Net Income and Gross profit
  • Figure 31. Univfy (United States) Revenue: by Geography 2019
  • Figure 32. Conceivable (United States) Revenue, Net Income and Gross profit
  • Figure 33. Conceivable (United States) Revenue: by Geography 2019
  • Figure 34. Global Femtech: by Type USD Million (2020-2025)
  • Figure 35. Global Femtech: by Application USD Million (2020-2025)
  • Figure 36. Global Femtech: by End User USD Million (2020-2025)
  • Figure 37. South America Femtech Share (%), by Country
  • Figure 38. Asia Pacific Femtech Share (%), by Country
  • Figure 39. Europe Femtech Share (%), by Country
  • Figure 40. MEA Femtech Share (%), by Country
  • Figure 41. North America Femtech Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Sustain Natural (United States)
  • Hera Med Ltd (Isreal)
  • Totohealth (Kenya)
  • Athena Feminine Technologies, Inc. (United States)
  • iSono Health (United States)
  • Sera Prognostics (United States)
  • Elvie (United Kingdom)
  • Univfy (United States)
  • Conceivable (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation